Attachment 1. Product Information for cobicistat
‘Erectile dysfunction and statin treatment in high cardiovascular risk patients.’ ... The published rates for the comparable outcome of "adverse events leading to discontinuation” in METEOR are 11% rosuvastatin vs 8% placebo (see JAMA 2007; 297: 1344-53 in Supporting Material).Note: If, on the other hand, it was intended that rates of all ... ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- watershed information for kids
- new product ideas for students
- health information for senior citizens
- background information for science projects
- heart health information for seniors
- nutritional information for starbucks
- reverse mortgage information for dummies
- medical information for seniors
- 1 product website
- product information sheet sample
- product information sheet template
- product information sheet template free